Latest Breaking News On - Aventis oncology - Page 1 : comparemela.com

FLORHAM PARK, N.J., Nov. 30, 2022 (GLOBE NEWSWIRE) Cellectar Biosciences, Inc. (NASDAQ: CLRB), a late-stage clinical biopharmaceutical company focused.

United statesJames carusoMonique kosseCellectar biosciencesShane leaAllos therapeuticsBachelor of business administrationLifesci advisorsImclone systemsCellectar biosciences incAbraxis bioscienceExchange commissionUniversity of louisiana monroeAventis oncologyBusiness administrationPhospholipid drug conjugate